Multi-model preclinical platform predicts clinical response of melanoma to immunotherapy
E. Perez-Guijarro, H. H. Yang, R. E. Araya, R. El Meskini, H. T. Michael, S. K. Vodnala, K. L. Marie, C. Graff-Cherry, S. Chin, A. J. Iacovelli, A. Kulaga, A. Fon, A. M. Michalowski, W. Hugo, R. S. Lo, , G. Merlino
The paper develops a preclinical platform using syngeneic mouse models to predict melanoma patient response to immunotherapy and identifies a melanocytic plasticity signature linked to treatment outcomes.
bioRxiv · Aug 6, 2019 · PreprintCancer Biology